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First  observed  in  cells  exposed  to  high  temperatures,  Heat  shock  proteins  (Hsps)  are  
nowadays  considered  the  most   important  cell  “chaperone”  complexes  over-­expressed  
in   response   to   a   number   of   cell   stress   stimuli.1   The   chaperone   activity   is   the   main  
function  of   the  eukaryotic  Heat  shock  protein  60  kDa  (Hsp60),   involved  in  the  capture  
and   refold  of   unfolded  or  misfolded   proteins.   Additional   roles   in   signal   transduction,2  
senescence  activation3  and  apoptosis4  have  been  ascribed  to  cytosolic  Hsp60.  During  
the   carcinogenIc   process,   in   vivo   studies   demonstrated   increased   levels   of   human  
Hsp60  in  several  organs,  such  as  uterine  exocervix,5  large  bowel,6  and  prostate.6  
In   this   context,   our   study   aims   to   elucidate   the   structural   details   of   the   interaction  
between   Hsp60   and   novel   designed   antagonists   able   to   specifically   block   this  
chaperonine.  A  preliminary   virtual   screening  of  24  million  molecules,   available   in   the  
Zinc  database,  was  carried  out  on  the  ATP-­binding  site  of  a  bacterial  Hsp60  monomer,  
the   coordinates   of   which   were   taken   from   Protein   Data   Bank   (ID:   1WE3),   figure   1.  
Compounds  with  high  affinity  were  further  refined  by  other  in  silico  protocols  previously  
and  successfully  applied  by  us  in  the  study  of  several  biological  targets.7  
  
  
Figure  1.  Bacterial  Hsp60  monomer  (left),  selected  benzofuran  core  structure  (right).  
  
The  analysis  of  virtual  screening   results  highlights   the  N-­{5-­[1H-­imidazol-­4-­yl-­methyl)-­
amino]-­benzofuran-­3-­yl}-­benzamides  of  type  1  as  interesting  series  for  the  inhibition  of  
Hsp60   ATP-­binding   site.   Selected   compounds   were   prepared   in   excellent   yields,  
following  appropriate  synthetic  pathways.  All  compounds  are  currently   tested   in  order  
to  proof  they  potential  anticancer  activity  as  modulator  of  Hsp60  function  in  tumor  cells.  
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